Showing results (51-60 of 1,586) with videos related to

Sort By:
Pageof 159
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|November 11, 1998
Bacterial extract OM85-BV induces interleukin-12-dependent IFN-gamma production by human CD4+ T cellsB Byl, M Libin, M Gérard, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 6, 2001
HIV-associated multinucleated giant cells in lymphoid tissue of the Waldeyer's ring: a detailed studyJ L Dargent, L Lespagnard, A Kornreich, et al.
The Journal of International Medical Research|February 26, 2000
Efficacy and safety of trazodone versus clorazepate in the treatment of HIV-positive subjects with adjustment disorders: a pilot studyS De Wit, L Cremers, D Hirsch, et al.
Clinical Endocrinology|June 1, 1978
A low T3 syndrome in diabetic ketoacidosisR Naeije, J Golstein, N Clumeck, et al.
HIV Medicine|January 27, 2005
Indinavir/ritonavir-based therapy in HIV-1-infected antiretroviral therapy-naive patients: comparison of 800/100 mg and 400/100 mg twice dailyD Konopnicki, S De Wit, B Poll, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|February 1, 1988
Salmonella bacteremia in African patients with human immunodeficiency virus infectionS De Wit, H Taelman, P Van de Perre, et al.
Epidemiology and Infection|February 17, 2017
Isolation unit for multidrug-resistant tuberculosis patients in a low endemic country, a step towards the World Health Organization End TB StrategyM C Payen, J P VAN Vooren, O Vandenberg, et al.
The Journal of Antimicrobial Chemotherapy|July 1, 1983
Ceftazidime as a single agent in the treatment of severe Pseudomonas aeruginosa infectionsN Clumeck, B Gordts, I Dab, et al.
Infection|July 1, 1983
Moxalactam therapy of serious infectionsP Van der Auwera, N Clumeck, Y Van Laethem, et al.
HIV Medicine|March 15, 2012
The MONET trial: week 144 analysis of the efficacy of darunavir/ritonavir (DRV/r) monotherapy versus DRV/r plus two nucleoside reverse transcriptase inhibitors, for patients with viral load < 50 HIV-1 RNA copies/mL at baselineJ R Arribas, N Clumeck, M Nelson, et al.
Pageof 159